标题
Omalizumab for atopic dermatitis: evidence for and against its use
作者
关键词
-
出版物
GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA
Volume 154, Issue 4, Pages -
出版商
Edizioni Minerva Medica
发表日期
2019-06-28
DOI
10.23736/s0392-0488.19.06302-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Methotrexate in the Treatment of Moderate to Severe Atopic Dermatitis: A Retrospective Study
- (2018) Nidhi Shah et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
- (2018) A. Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Omalizumab an effective and safe alternative therapy in severe refractory atopic dermatitis
- (2018) Maria Maddalena Sirufo et al. MEDICINE
- Omalizumab for the treatment of chronic severe atopic dermatitis and urticaria
- (2018) JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- OMALIZUMAB IMPROVES SEVERE ATOPIC DERMATITIS WITH VERY HIGH IGE
- (2018) C. Song et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Rapid, persistent, and simultaneous remission of urticaria and severe atopic dermatitis after treatment with omalizumab
- (2018) Ester Del Duca et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Chronic urticaria in a child affected by atopic dermatitis: effective treatment with omalizumab
- (2018) Lucia Leonardi et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety
- (2017) Ana M Giménez-Arnau EXPERT OPINION ON BIOLOGICAL THERAPY
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
- (2017) Andrew Blauvelt et al. LANCET
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Personalized treatment of severe atopic dermatitis in a child: A 10-year follow-up
- (2017) Simona Barni et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- The role of anti-IgE (omalizumab/Xolair) in the management of severe recalcitrant paediatric atopic eczema (ADAPT): statistical analysis plan
- (2017) Tao Chen et al. Trials
- Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial
- (2017) Susan Chan et al. Trials
- Targeting IgE in Severe Atopic Dermatitis with a Combination of Immunoadsorption and Omalizumab
- (2016) A Zink et al. ACTA DERMATO-VENEREOLOGICA
- Omalizumab for atopic dermatitis: case series and a systematic review of the literature
- (2016) Jesper Grønlund Holm et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Outcome of treatment with azathioprine in severe atopic dermatitis: a 5-year retrospective study of adult outpatients
- (2015) S.F. Thomsen et al. BRITISH JOURNAL OF DERMATOLOGY
- Omalizumab for Difficult-to-Treat Dermatological Conditions: Clinical and Immunological Features from a Retrospective Real-Life Experience
- (2015) Ciro Romano et al. CLINICAL DRUG INVESTIGATION
- Vernal Keratoconjunctivitis and immune-mediated diseases: One unique way to symptom control?
- (2015) Francesca Occasi et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Pathogenesis of atopic dermatitis
- (2014) Eung Ho Choi et al. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION
- Long-term Treatment of Severe Recalcitrant Atopic Dermatitis with Omalizumab, an Anti-immuno-globulin E
- (2013) S Quist et al. ACTA DERMATO-VENEREOLOGICA
- Increased efficacy of omalizumab in atopic dermatitis patients with wild-type filaggrin status and higher serum levels of phosphatidylcholines
- (2013) M. Hotze et al. ALLERGY
- Immunologic Effects of Omalizumab in Children with Severe Refractory Atopic Dermatitis: A Randomized, Placebo-Controlled Clinical Trial
- (2013) Shuba Rajashri Iyengar et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Anti-IgE therapy and severe atopic dermatitis: A pediatric perspective
- (2013) Jonathan Lacombe Barrios et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Anti-immunoglobulin E in the treatment of refractory atopic dermatitis
- (2012) D. H. Kim et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Combined therapy with low-dose omalizumab and intravenous immunoglobulin for severe atopic dermatitis. Report of four cases
- (2011) F. Toledo et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Recalcitrant Atopic Dermatitis Treated with Omalizumab
- (2010) Se-Young Park et al. Annals of Dermatology
- Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study
- (2010) Peter Maximilian Heil et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Omalizumab efficacy in a girl with atopic eczema
- (2009) C. Caruso et al. ALLERGY
- Efficacy of omalizumab in the treatment of atopic dermatitis: A pilot study
- (2008) Lee E. Sheinkopf et al. ALLERGY AND ASTHMA PROCEEDINGS
- Omalizumab for patients with severe and therapy-refractory atopic eczema?
- (2008) Christian Andres et al. CURRENT ALLERGY AND ASTHMA REPORTS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now